Insiders · Profile

Zawel Leigh

See Remarks at Cullinan Therapeutics. Filing since 9 Aug 2021. CIK 0001837456

Company

Date

Role

Action

Amount

Of holding

CGEM Cullinan Therapeutics, Inc.

15 Oct 2021

See Remarks

Sold, plan not stated

19,574

$489.35K

34.4%

CGEM Cullinan Therapeutics, Inc.

7 Oct 2021

See Remarks

Sold, plan not stated

1,079

$26.98K

1.9%

CGEM Cullinan Therapeutics, Inc.

20 Sep 2021

See Remarks

Sold, plan not stated

7,468

$187.89K

11.4%

CGEM Cullinan Therapeutics, Inc.

7 Sep 2021

See Remarks

Sold, plan not stated

28,118

$814.02K

30.1%

CGEM Cullinan Therapeutics, Inc.

23 Aug 2021

See Remarks

Sold, plan not stated

28,118

$815.42K

23.1%

CGEM Cullinan Therapeutics, Inc.

10 Aug 2021

See Remarks

Sold, plan not stated

6,914

$189.52K

5.4%

CGEM Cullinan Therapeutics, Inc.

9 Aug 2021

See Remarks

Sold, plan not stated

21,204

$563.33K

14.2%

7 decisions on file.